Abstract:Abstract There has been an increasing role in the use of injectable fillers for rejuvenation of the aging face. In this systematic review, we aim to evaluate the existing literature related to soft tissue fillers of the midface. Specifically, we focus on the non-hyaluronic acid fillers including polymethylmethacrylate (PMMA), poly-L-lactic acid (PLLA), calcium hydroxyapatite (CaHA), and autologous fat. A systematic review was conducted in November 2020 in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines with PubMed and Embase databases. Medical Subject Headings terms used were “cheek” OR “midface” OR “malar” and “filler” OR “poly-L-lactic acid” OR “calcium hydroxyapatite,” “autologous fat” OR “polymethylmethacrylate” OR “Artefill” OR “Bellafill” OR “Radiesse” OR “Sculptra.” The initial search identified 271 articles. After 145 duplicates were removed, 126 studies were screened for relevance by title and abstract. A total of 114 studies were eliminated based on inclusion and exclusion criteria. Twelve articles underwent full-text review. Seven articles were included in the final analysis consisting of four non-hyaluronic filler products: PMMA, PLLA, CaHA, autologous fat. Most patients were highly satisfied with their results. Due to the gradual volumizing effects of PMMA, PLLA, and CaHA, patient satisfaction generally improved over time. Minor adverse reactions related to treatment included bruising, swelling, and pain. Nodule formation was reported in PLLA and CaHA studies. For autologous fat, 32% of the original injection volume remained at 16 months post-treatment, which still provided clinically improved malar enhancement. Dermal fillers are an attractive treatment option for the aging face due to their high patient satisfaction, long-lasting effects, and low side-effect profile. Patients should be appropriately counseled on the delayed effects of non-HA fillers. Autologous fat is a good option in many patients with the major drawback of unpredictable longevity, which may require a secondary procedure. Future studies should examine the longevity and long-term side effects of these fillers.

Facial Soft-Tissue Augmentation with Injectable Autologous and Allogeneic Human Tissue Collagen Matrix (Autologen and Dermalogen)

Collagen-Containing Fillers: Alone and in Combination

Autologous Facial Fat Transfer: Soft Tissue Augmentation and Regnenerative Therapy

Soft-Tissue Augmentation and the Role of Poly-L-Lactic Acid

Injectable fillers: review of material and properties

Injectable soft-tissue fillers: clinical overview

Non-Hyaluronic Acid Fillers for Midface Augmentation: A Systematic Review

CosmoDerm/CosmoPlast (Human Bioengineered Collagen) for the Aging Face

A Novel Hybrid Injectable for Soft-tissue Augmentation: Analysis of Data and Practical Experience

A Novel Injectable Fibroblasts-Porous PDLLA Microspheres/collagen Gel Composite for Soft-Tissue Augmentation

Expanding Treatment Options for Injectable Agents

Injectable Soft Tissue Nano/Micro Fillers For Facial Reconstruction

Injectable Soft Tissue Nano/Micro Fillers for Facial Reconstruction.

Permanent Facial Fillers: Addressing Complications and Advancing Solutions

Application of Facial Fat Injections

Fat, Stem Cells, and Platelet-Rich Plasma

A Personalized Protocol for Facial Rejuvenation Using Two Soft Hyaluronic Acid Fillers With High Cohesivity

Injection Guidelines for Treating Midface Volume Deficiency With Hyaluronic Acid Fillers: The ATP Approach (Anatomy, Techniques, Products)

Surgery for Foreign Body Reactions due to Injectable Fillers

Intradermal Fillers for Minimally Invasive Treatment of Facial Aging

Silicone, Fibrel, and Collagen Implantation for Facial Lines and Wrinkles